Dr. Guggina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
221 Longwood Ave
Boston, MA 02115
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine/Dermatology, 2012 - 2017
Indiana University School of MedicineClass of 2012
Certifications & Licensure
MA State Medical License 2020 - 2026
IL State Medical License 2015 - 2020- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsDefining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner
Journal for Immunotherapy of Cancer. 2024-04-10 - 3 citationsIncidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer: A Systematic Review and Meta-analysis.Abdulhadi Jfri, Rachel Meltzer, Arash Mostaghimi, Nicole LeBoeuf, Lauren Guggina
JAMA Oncology. 2022-10-13 - 1 citationsPerceptions of telehealth among inpatient consultative dermatology providers and practice patterns during COVID-19.Lida Zheng, Lauren M Guggina, Xiaolong A Zhou, Karolyn A Wanat, Joaquin C Brieva
Archives of Dermatological Research. 2023-10-01
Press Mentions
Meta-Analysis Reveals High Risk for Cutaneous AEs with PI3K InhibitorsOctober 18th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
